Some of our projects include:

- Revising TGF grant co-financing requirements, leading analytical and modeling group to conduct economic evaluations, access to market, risk and impact modeling. The Global Fund – Geneva (TGF)

- Led Economic Evaluation (Cost Effectiveness analysis) of Moxidectin versus Ivermectin, and present the results to key stakeholders, Bill and Melinda Gates Foundation (BMGF)

- Conducted Economic Evaluation Assessment of Obesity in 3 countries and published the article. Novo Nordisk Pharma - Copenhagen

- Provided key recommendations of HIS design to support national clinical trials and tracking of expenditures. WHO- Geneva

- Performed Health economic outcomes modeling to prepare HTA dossier for diabetes medicines. Novo Nordisk Pharma

- Conducted Technical and Allocative Efficiency, Impact Analysis of HIV programme investments and national HIV costing exercise. UNAIDS - Geneva

- Board Advisor, Revised Investment Case of Introduction/Switching of PCV 15 to PCV 20 – Translation Economic Evaluation Evidence Review, Pfizer

- Conducted Markov modeling and HTA adaptation (in 7 countries) of Switching between PCV 13/15/20, Pfizer

- Developed Covid 19 Preparedness and Response Investment and Costing framework, German Development Bank - Frankfurt (KfW)

- Provided key modeling inputs in the development of effects of air pollutants on morbidity; developed methodology for costing and economic evaluation, WHO HQ, Geneva

- Conducted various types of risk and burden of cardiovascular disease analysis, WHO Copenhagen

- Developed Structural Equation Model (SEM) to assess an effect of latent Social Enablers constructs on HIV/AIDS Health Outcomes, UNAIDS - Geneva

- Conducted Feasibility Study of Application of Block Chain Technology.     GFA consulting group-Hamburg

- Led and modelled Cost-Effective and Cost-Benefit study of Team-Based Healthcare of Multi-diagnosis and complex patients. The Geneva University Hospital (HUG)

- Reviewed HTA submissions. Federal Swiss Office of Public Health – Geneva         

- Conducted Economic Evaluation Assessment of CD4 levels:  Cost- Effectiveness of treatment for Newly Diagnosed People Living with HIV. Guy's and St. Thomas Hospital, London

- Development of Costing Methodology in HUG.  Department of Social Affairs, Economics and Health (DEAS), Geneva